Project Review Case Study White Paper Technology Overview Healthcare Manufacturing Pharmaceutical Portfolio Government Logistics Financial Business Client Genre Vertical This biotech company’s only final stage bio-manufacturing facility in the world was struggling to meet rapidily increasing customer demand. Repeated unanticipated production delays and starvations at critical parts of the operation were causing not only late and missed deliveries, but the expiration of batches of product at a cost of approximately $1 million per batch. The production team at the facility had not been able to identify the root cause of the delays, nor find a suitable solution. As a result, they were planning to invest $1.2 billion to add another 500,000 square feet to the exsiting biotechnology bul

Join for free to read